Press Releases Vaxxinity, Inc.

Equities

VAXX

US92244V1044

Market Closed - OTC Markets Other stock markets 03:59:47 2024-05-17 pm EDT			5-day change	1st Jan Change
0.081 ^USD	+45.95%		+58.82%	-90.47%

May. 13	Vaxxinity, Inc.(OTCPK:VAXX) dropped from S&P Global BMI Index	CI
May. 13	Vaxxinity, Inc.(OTCPK:VAXX) dropped from S&P TMI Index	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Vaxxinity Issues Shareholder Letter	Apr. 19	AQ
Vaxxinity Issues Shareholder Letter	Apr. 19	GL
Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock	Apr. 19	GL
Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting	Mar. 28	GL
Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Updates	Mar. 27	GL
Vaxxinity : UB-312 Target Engagement - ADPD 2024	Mar. 12	PU
Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson’s Disease at AD/PD™ 2024	Mar. 07	GL
Vaxxinity’s Cholesterol Vaccine Candidate Successfully Lowers LDL-C: Preclinical Data Published	Feb. 15	GL
Vaxxinity to Present Clinical and Preclinical Pipeline Data at AD/PD 2024	Feb. 13	GL
Vaxxinity to Present Clinical and Preclinical Pipeline Data at AD/PD 2024	Feb. 13	AQ
Vaxxinity Announces Research Collaboration on Active Immunotherapies for Neurodegenerative Diseases with University of Florida	Jan. 30	GL
Vaxxinity Announces Research Collaboration on Active Immunotherapies for Neurodegenerative Diseases with University of Florida	Jan. 30	AQ
Vaxxinity Announces Collaboration on Space Medicine Research with University of Central Florida	Jan. 18	GL
Vaxxinity Announces Collaboration on Space Medicine Research with University of Central Florida	Jan. 18	AQ
Vaxxinity to Present at the 2024 J.P. Morgan Healthcare Conference	Jan. 03	GL
Vaxxinity to Present at Upcoming November Medical and Investor Conferences	Nov. 13	GL
Vaxxinity to Present at Upcoming November Medical and Investor Conferences	Nov. 13	AQ
Vaxxinity Reports Third Quarter 2023 Financial Results and Provides Corporate Update	Nov. 08	GL
Vaxxinity Reports Third Quarter 2023 Financial Results and Provides Corporate Update	Nov. 08	AQ
Vaxxinity : H.C. Wainwright 25th Annual Global Investment Conference	23-09-11	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Vaxxinity, Inc.

Equities

VAXX

US92244V1044

Press Releases

Filters